Buccal Swab
Sponsors
Virginia Commonwealth University, Augusta University, Northwestern University, Universitaire Ziekenhuizen KU Leuven, Institut Paoli-Calmettes
Conditions
Acute LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia, Relapsed, AdultAdverse Drug ReactionAgedAtopic DermatitisBone Marrow Failure SyndromeCancer
Phase 1
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
RecruitingNCT06514261
Start: 2024-12-18End: 2026-09-16Target: 45Updated: 2026-04-03
Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment
SuspendedNCT06888323
Start: 2026-04-27End: 2027-12-31Target: 30Updated: 2026-04-03
Phase 2
Unknown Phase
Histamine Pharmacogenetics in Children With Atopic Dermatitis
CompletedNCT00277433
Start: 2004-06-30End: 2009-12-31Updated: 2017-03-20
Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure
CompletedNCT00384241
Start: 2006-08-31End: 2009-07-31Updated: 2015-06-03
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
CompletedNCT01016106
Start: 2010-06-30End: 2011-09-30Updated: 2015-05-01
Comparison of the Methylation Pattern of DNA in Buccal Swabs From Different Time Points
TerminatedNCT02297009
Start: 2014-12-31End: 2024-07-31Updated: 2024-07-16
Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015
NCT02320656
Start: 2014-05-31End: 2024-05-31Target: 650Updated: 2018-07-26
Aging, Geriatric Syndromes and Clonal Hematopoiesis
RecruitingNCT02604563
Start: 2016-03-10End: 2030-04-30Target: 2000Updated: 2025-04-25
Genetic Basis of Rosacea
CompletedNCT02787616
Start: 2012-04-13End: 2018-11-16Updated: 2019-09-26
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
RecruitingNCT02958462
Start: 2017-01-16End: 2035-09-15Target: 2000Updated: 2026-02-23
Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
RecruitingNCT04154553
Start: 2019-10-15End: 2026-08-31Target: 400Updated: 2025-05-14
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Active, not recruitingNCT04263181
Start: 2020-01-29End: 2027-01-31Updated: 2026-03-02
Patient Derived Preclinical Models
RecruitingNCT05324553
Start: 2022-04-06End: 2028-03-31Target: 50Updated: 2025-05-02